TY - JOUR
T1 - A case report of pediatric paraneoplastic dysautonomia
AU - Harer, Katherine
AU - Mann, Jennifer
AU - Muhlbauer, Nicole
AU - Welch, Jennifer
AU - Alverson, Brian
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2020/12
Y1 - 2020/12
N2 - We present the case of a 16-year-old girl who presented with severe refractory orthostatic hypotension secondary to pandysautonomia. Initially, she was treated for Guillain-Barré syndrome given clinical symptoms and increased protein on cerebrospinal fluid, but the severity of symptoms and lack of response to intravenous immunoglobulin prompted further evaluation for an autoimmune etiology. She was ultimately diagnosed with paraneoplastic neuropathy secondary to Hodgkin lymphoma. Paraneoplastic neurologic phenomena are rare, occurring in just 0.01% of cancers, and prompt recognition is crucial for initiating appropriate therapy. Rapid progression of severe disabling symptoms should raise suspicion for an underlying malignancy. The patient had limited response to splanchnic vasoconstrictors in addition to -agonists, anticholinergics, and mineralocorticoids until initiation of modified Hodgkin lymphoma directed chemotherapy plus rituximab.
AB - We present the case of a 16-year-old girl who presented with severe refractory orthostatic hypotension secondary to pandysautonomia. Initially, she was treated for Guillain-Barré syndrome given clinical symptoms and increased protein on cerebrospinal fluid, but the severity of symptoms and lack of response to intravenous immunoglobulin prompted further evaluation for an autoimmune etiology. She was ultimately diagnosed with paraneoplastic neuropathy secondary to Hodgkin lymphoma. Paraneoplastic neurologic phenomena are rare, occurring in just 0.01% of cancers, and prompt recognition is crucial for initiating appropriate therapy. Rapid progression of severe disabling symptoms should raise suspicion for an underlying malignancy. The patient had limited response to splanchnic vasoconstrictors in addition to -agonists, anticholinergics, and mineralocorticoids until initiation of modified Hodgkin lymphoma directed chemotherapy plus rituximab.
KW - Guillain-Barré syndrome
KW - Hodgkin lymphoma
KW - orthostatic hypotension
KW - pandysautonomia
KW - paraneoplastic neuropathy
UR - http://www.scopus.com/inward/record.url?scp=85097002897&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097002897&partnerID=8YFLogxK
U2 - 10.1097/PEC.0000000000001558
DO - 10.1097/PEC.0000000000001558
M3 - Article
C2 - 30045352
AN - SCOPUS:85097002897
SN - 0749-5161
VL - 36
SP - E742-E744
JO - Pediatric emergency care
JF - Pediatric emergency care
IS - 12
ER -